Growth Metrics

Bio-Techne (TECH) Cost of Revenue (2016 - 2026)

Bio-Techne has reported Cost of Revenue over the past 17 years, most recently at $104.6 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 1.41% year-over-year to $104.6 million; the TTM value through Dec 2025 reached $422.8 million, up 2.83%, while the annual FY2025 figure was $429.4 million, 10.28% up from the prior year.
  • Cost of Revenue for Q4 2025 was $104.6 million at Bio-Techne, up from $98.4 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $118.2 million in Q2 2025 and troughed at $75.3 million in Q1 2021.
  • A 5-year average of $94.8 million and a median of $94.0 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 32.89% in 2021 and later decreased 7.51% in 2025.
  • Year by year, Cost of Revenue stood at $85.6 million in 2021, then increased by 3.08% to $88.2 million in 2022, then increased by 8.83% to $96.0 million in 2023, then rose by 7.43% to $103.1 million in 2024, then increased by 1.41% to $104.6 million in 2025.
  • Business Quant data shows Cost of Revenue for TECH at $104.6 million in Q4 2025, $98.4 million in Q3 2025, and $118.2 million in Q2 2025.